TFF Pharmaceuticals, Inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology.
Our patented Thin Film Freezing (TFF) platform makes it possible to turn more molecules into inhalable therapies. This novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities.
TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tac-Lac Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally.
Up to 90% verified emails and mobile numbers, refreshed weekly.
TFF Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.
TFF Pharmaceuticals, Inc. has approximately 2-10 employees employees.
TFF Pharmaceuticals, Inc. is based in Austin, Texas, United States.
Yes. TFF Pharmaceuticals, Inc. is a publicly traded company.
You can reach TFF Pharmaceuticals, Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.